subgroup
of
drug)
→
ReceivesAction
→
described in section 505(a
Typicality: | 0.537 |
Saliency: | 0.671 |
of the act | 45 | other |
new drug → be described in → section 505(a | 46 |
negative | neutral | positive |
0.445 | 0.535 | 0.020 |
Raw frequency | 46 |
Normalized frequency | 0.671 |
Modifier score | 0.500 |
Perplexity | 329.785 |